These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3273418)

  • 21. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the pathogenesis of subacute sclerosing panencephalitis.
    Brzosko WJ; Laskowski ZK; Dabrowska-Bernstein B; Matacz D; Kulczycki J; Płachcińska J
    Neuropatol Pol; 1984; 22(1):23-38. PubMed ID: 6234480
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies of measles antibodies in subacute sclerosing panencephalitis].
    Zwoździak W; Galas-Zgorzalewicz B
    Pediatr Pol; 1972 Oct; 47(10):1247-54. PubMed ID: 5085409
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE.
    Tourtellotte WW; Ma BI; Brandes DB; Walsh MJ; Potvin AR
    Ann Neurol; 1981 Jun; 9(6):551-6. PubMed ID: 7259117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE).
    Dyken PR
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):217-25. PubMed ID: 11553938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low molecular weight measles immunoglobulin M in subacute sclerosing panencephalitis and acute measles.
    Connolly JH; Simpson DM; Trudgett A; Hopkins AP
    Postgrad Med J; 1985 May; 61(715):407-10. PubMed ID: 4022875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with acute, fulminant form of SSPE.
    Hergüner MO; Altunbaşak S; Baytok V
    Turk J Pediatr; 2007; 49(4):422-5. PubMed ID: 18246746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial subacute sclerosing panencephalitis associated with short latency.
    Sharma V; Gupta VB; Eisenhut M
    Pediatr Neurol; 2008 Mar; 38(3):215-7. PubMed ID: 18279759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of anti-CD9 antibodies in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
    Shimizu T; Matsuishi T; Iwamoto R; Handa K; Yoshioka H; Kato H; Ueda S; Hara H; Tabira T; Mekada E
    J Infect Dis; 2002 May; 185(9):1346-50. PubMed ID: 12001055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amyloid A (SAA) in viral infection: rubella, measles and subacute sclerosing panencephalitis (SSPE).
    Shainkin-Kestenbaum R; Zimlichman S; Winikoff Y; Pras M; Chaimovitz C; Sarov I
    Clin Exp Immunol; 1982 Dec; 50(3):503-6. PubMed ID: 7165997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fulminating subacute sclerosing panencephalitis: case report and literature review.
    PeBenito R; Naqvi SH; Arca MM; Schubert R
    Clin Pediatr (Phila); 1997 Mar; 36(3):149-54. PubMed ID: 9078417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subacute sclerosing panencephalitis.
    Graves MC
    Neurol Clin; 1984 May; 2(2):267-80. PubMed ID: 6334226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea.
    Ichiyama T; Siba P; Suarkia D; Reeder J; Takasu T; Miki K; Maeba S; Furukawa S
    Cytokine; 2006 Jan; 33(1):17-20. PubMed ID: 16413199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Virus infection in the central nervous system: immunological abnormalities in SSPE].
    Sato T; Anno M; Takeda K; Uchiyama T; Togashi T
    No To Shinkei; 1983 May; 35(5):443-9. PubMed ID: 6414494
    [No Abstract]   [Full Text] [Related]  

  • 36. SSPE treated with isoprinosine: immunopathological observations.
    Streletz LJ; Sethi BS; Graziani LJ; Duckett SW
    Ann Neurol; 1985 Jan; 17(1):105-6. PubMed ID: 2580477
    [No Abstract]   [Full Text] [Related]  

  • 37. Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children.
    Lucas KM; Sanders RC; Rongap A; Rongap T; Pinai S; Alpers MP
    Epidemiol Infect; 1992 Jun; 108(3):547-53. PubMed ID: 1601084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subacute sclerosing panencephalitis and measles virus.
    Norrby E
    Ann Clin Res; 1973 Oct; 5(5):288-92. PubMed ID: 4599898
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnostic and pathogenetic aspects of subacute sclerosing panencephalitis.
    Gnehm HE; Roux L; Suter S
    Helv Paediatr Acta; 1986 Aug; 41(3):209-20. PubMed ID: 3759483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of lymphocyte subgroups in children with subacute sclerosing panencephalitis.
    Yilmaz C; Yuca SA; Yilmaz N; Oner AF; Caksen H
    J Int Med Res; 2009; 37(3):828-34. PubMed ID: 19589266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.